These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. [Angiopathy and the eye]. Rencová E Vnitr Lek; 2010 Apr; 56(4):333-9. PubMed ID: 20465107 [TBL] [Abstract][Full Text] [Related]
28. Update on the treatment of diabetic retinopathy. Yam JC; Kwok AK Hong Kong Med J; 2007 Feb; 13(1):46-60. PubMed ID: 17277392 [TBL] [Abstract][Full Text] [Related]
29. Vascular endothelial growth factor and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives. Caldwell RB; Bartoli M; Behzadian MA; El-Remessy AE; Al-Shabrawey M; Platt DH; Caldwell RW Diabetes Metab Res Rev; 2003; 19(6):442-55. PubMed ID: 14648803 [TBL] [Abstract][Full Text] [Related]
30. [Epidemiology, pathogenesis and therapy of diabetic retinopathy and maculopathy]. Jochmann C; Hammes HP Z Arztl Fortbild Qualitatssich; 2002 Mar; 96(3):167-74. PubMed ID: 12017760 [TBL] [Abstract][Full Text] [Related]
32. [Cryocoagulation in therapy of proliferative diabetic retinopathy]. Pauleikhoff D; Engineer B; Wessing A Klin Monbl Augenheilkd; 1997 Mar; 210(3):147-52. PubMed ID: 9206746 [TBL] [Abstract][Full Text] [Related]
33. The Role of Plasma Kallikrein-Kinin Pathway in the Development of Diabetic Retinopathy: Pathophysiology and Therapeutic Approaches. Abdulaal M; Haddad NM; Sun JK; Silva PS Semin Ophthalmol; 2016; 31(1-2):19-24. PubMed ID: 26959125 [TBL] [Abstract][Full Text] [Related]
34. The prognostic value of post-treatment retinopathy after panretinal photocoagulation for proliferative diabetic retinopathy in type 1 diabetes. Bek T; Kjaergaard J Eur J Ophthalmol; 2004; 14(6):538-42. PubMed ID: 15638104 [TBL] [Abstract][Full Text] [Related]
35. The pathogenesis of diabetic retinopathy: old concepts and new questions. Cai J; Boulton M Eye (Lond); 2002 May; 16(3):242-60. PubMed ID: 12032713 [TBL] [Abstract][Full Text] [Related]
36. Diabetic retinopathy: a leading cause of new blindness. Haik GM; Terrell WL; Haik GM South Med J; 1989 May; 82(5):575-9. PubMed ID: 2655102 [TBL] [Abstract][Full Text] [Related]
37. Predominant cone photoreceptor dysfunction in a hyperglycaemic model of non-proliferative diabetic retinopathy. Alvarez Y; Chen K; Reynolds AL; Waghorne N; O'Connor JJ; Kennedy BN Dis Model Mech; 2010; 3(3-4):236-45. PubMed ID: 20142328 [TBL] [Abstract][Full Text] [Related]
38. Serous retinal detachment after panretinal photocoagulation for proliferative diabetic retinopathy: a case report. Schatz P; Aldayel A; Taskintuna I; Abdelkader E; Mura M J Med Case Rep; 2017 Sep; 11(1):265. PubMed ID: 28923115 [TBL] [Abstract][Full Text] [Related]
39. [What is the etiology of diabetic retinopathy?]. Wiedemann P Ophthalmologe; 1993 Oct; 90(5):426-33. PubMed ID: 8219625 [TBL] [Abstract][Full Text] [Related]
40. Novel role of erythropoietin in proliferative diabetic retinopathy. Takagi H; Watanabe D; Suzuma K; Kurimoto M; Suzuma I; Ohashi H; Ojima T; Murakami T Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S62-4. PubMed ID: 17481772 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]